A 3-day meeting of the CDC’s Advisory Committee on Immunization Practices that was scheduled for next week has been called ...

NIH Director Jay Bhattacharya, MD, PhD, has been picked to also serve as acting director of the CDC, a White House official ...

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and ...

Reversing its initial decision, the FDA has agreed to review Moderna’s messenger RNA-based influenza vaccine for approval, the company announced Wednesday. The reversal about weeks after the FDA sent ...

Higher-order aberrations were corrected by around 75% in eyes with keratoconus fitted with Zenlens Chroma HOA, according to data presented at the Global Specialty Lens Symposium.“Patients with ...

Primary care use among patients receiving in-center hemodialysis was associated with lower mortality rates but more hospitalizations and ED visits, according to study data published in Kidney Medicine ...

According to data presented at the Radiological Society of North America Annual Meeting, ACL tears were seen with higher frequency in men vs. women in patients who presented for MRI with a primary ...

The cardiology landscape is rapidly evolving. Novel risk factors and new tools are reshaping CV risk assessment and management.Healio | Cardiology Today asked cardiologists: What are the most ...

In this expert perspective from Retina 2026, Murtaza K. Adam, MD, of Colorado Retina Associates, discusses real-world data coming in 2026.He said he is excited about data on Eylea HD (aflibercept 8 mg ...

Long-term evaluation of the randomized ASPREE trial and an observational follow-up study confirmed prior results that low-dose aspirin did not reduce cancer incidence among older adults and ...

The expanded age indication is supported by results from a 3-year FDA clinical trial that included 629 eyes. The EVO ICL demonstrated “a strong safety profile” with no reported cases of pupillary ...

The median predicted survival age of a patient with cystic fibrosis in 2020 to 2024 was 65 years, a 19-year increase from 2015 to 2019, according to data from the 2024 Cystic Fibrosis National ...